Peer-reviewedCC BY-NC-NDTranslational cancer research
Prognostic value of neutrophil-to-lymphocyte ratio in nasopharyngeal carcinoma: a systematic review and meta-analysis of 30 cohorts through June 30, 2026
- 1Department of Otorhinolaryngology Head and Neck Surgery , First Affiliated Hospital of Guangxi Medical University , Nanning , ;
- 2Department of Head and Neck Surgery , the Affiliated Tumor Hospital of Guangxi Medical University , Nanning , ;
- 3Department of Radiation Oncology , First Affiliated Hospital of Guangxi Medical University , Nanning ,
Related
- Prognostic value of the neutrophil-to-lymphocyte ratio in patients with colorectal cancer undergoing chemotherapy: a systematic review and meta-analysis
- The Prognostic Value of Baseline Neutrophil-to-Lymphocyte Ratio for Mortality in Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis.
- Admission blood glucose and neutrophil-to-lymphocyte ratio provide independent and complementary prognostic value for in-hospital mortality in acute type A aortic dissection
- Beyond Prognosis: A Systematic Review of the Neutrophil-to-Lymphocyte Ratio as a Modifiable Cardiovascular Biomarker
- Prognostic value of the hemoglobin, albumin, lymphocyte, and platelet score in nonmetastatic renal cell carcinoma after nephrectomy
BibTeX
@article{lu2026prognostic,
title = {{Prognostic value of neutrophil-to-lymphocyte ratio in nasopharyngeal carcinoma: a systematic review and meta-analysis of 30 cohorts through June 30, 2026}},
author = {Yunliang Lu and Biaoyou Chen and Jingfeng Ye and Xinyi Hu and Tingting Jiang and Zhe Zhang and Tingting Huang},
journal = {Translational cancer research},
year = {2026},
month = aug,
url = {https://europepmc.org/article/PMC/PMC13657807},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Prognostic value of neutrophil-to-lymphocyte ratio in nasopharyngeal carcinoma: a systematic review and meta-analysis of 30 cohorts through June 30, 2026
AU - Yunliang Lu
AU - Biaoyou Chen
AU - Jingfeng Ye
AU - Xinyi Hu
AU - Tingting Jiang
AU - Zhe Zhang
AU - Tingting Huang
PY - 2026
DA - 2026/08/11
JO - Translational cancer research
UR - https://europepmc.org/article/PMC/PMC13657807
SN - 2218-676X
ER -